Page last updated: 2024-08-24

liarozole and Metastase

liarozole has been researched along with Metastase in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boccardo, F; Brune, D; Bruynseels, J; De Porre, P; Debruyne, FJ; Denis, L; Fradet, Y; Janssens, M; Johansson, JE; Marberger, JM; Murray, R; Rassweiler, J; Tyrrell, C; Vangeneugden, T1
Abdolell, M; Blackstein, M; Clemons, M; Crump, M; De Coster, R; Goel, R; Goss, PE; Kaizer, L; Marques, R; Nabholtz, JM; Oza, A; Qi, S; Sterns, EE; Strasser, K1
Denis, L; Mahler, C1

Reviews

1 review(s) available for liarozole and Metastase

ArticleYear
Management of relapsing disease in prostate cancer.
    Cancer, 1992, Jul-01, Volume: 70, Issue:1 Suppl

    Topics: Aminoglutethimide; Androgen Antagonists; Antineoplastic Agents; Combined Modality Therapy; Estrogens; Humans; Imidazoles; Ketoconazole; Male; Neoplasm Metastasis; Orchiectomy; Palliative Care; Prostatic Neoplasms; Recurrence

1992

Trials

2 trial(s) available for liarozole and Metastase

ArticleYear
Liarozole--a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate. Liarozole Study Group.
    Urology, 1998, Volume: 52, Issue:1

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Cyproterone Acetate; Disease Progression; Humans; Imidazoles; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate

1998
Liarozole fumarate (R85246): in the treatment of ER negative, tamoxifen refractory or chemotherapy resistant postmenopausal metastatic breast cancer.
    Breast cancer research and treatment, 2000, Volume: 64, Issue:2

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Estradiol; Female; Humans; Imidazoles; Mammary Neoplasms, Experimental; Middle Aged; Neoplasm Metastasis; Postmenopause; Quality of Life; Rats; Receptors, Estrogen; Tamoxifen; Treatment Outcome

2000